Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting
Michael J. Tisdale
*
*
Corresponding author for this work
Aston Pharmacy School
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
13%
Animal Models
11%
Antibodies
8%
Atrophy
13%
Burns
16%
Cachexia
19%
Cytokines
19%
Eicosapentaenoic Acid
19%
Enzymes
8%
Glucocorticoid Receptors
17%
Glucocorticoids
14%
Ibuprofen
18%
Insulin
21%
Muscle Proteins
18%
Muscles
57%
Myosins
17%
Neoplasms
5%
NF-kappa B
51%
Oxidative Stress
11%
Proteasome Endopeptidase Complex
100%
Proteins
11%
Proteolysis
75%
Reactive Oxygen Species
12%
Renal Insufficiency
14%
Resveratrol
18%
Sepsis
25%
Skeletal Muscle
50%
Thalidomide
19%
Therapeutics
15%
Transcription Factors
12%
Ubiquitin
96%
Wounds and Injuries
7%